Cargando…
Performance of Aptima HPV E6/E7 mRNA Test for Detection of Cervical Lesions in a Large Chinese Population
BACKGROUND: We aimed to examine the effectiveness of Aptima HPV E6/E7 mRNA test for detection of cervical lesions in a large Chinese population. METHODS: Overall, 4,350 women, who received simultaneously Aptima HPV E6/E7 mRNA test and HPV DNA test, followed by cervical biopsy in the Department of Gy...
Autores principales: | Yang, Zhujuan, Zhu, Weipei, Liu, Yan, Chen, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745397/ https://www.ncbi.nlm.nih.gov/pubmed/36561247 http://dx.doi.org/10.18502/ijph.v51i11.11172 |
Ejemplares similares
-
Do women with high-risk HPV E6/E7 mRNA test positivity and NILM cytology need colposcopy?
por: Liu, Ying, et al.
Publicado: (2023) -
Accuracy of HPV E6/E7 mRNA examination using in situ hybridization in diagnosing cervical intraepithelial lesions
por: Hui, Chang, et al.
Publicado: (2021) -
The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer
por: Xu, Yating, et al.
Publicado: (2023) -
The Potential Benefits of HPV E6/E7 mRNA Test in Cervical Cancer Screening in China
por: Zhang, Shao-Kai, et al.
Publicado: (2020) -
Triage of Women with Minor Cervical Lesions: Data Suggesting a “Test and Treat” Approach for HPV E6/E7 mRNA Testing
por: Sørbye, Sveinung Wergeland, et al.
Publicado: (2010)